Updates in Urologic Oncology
When it comes to defeating cancer, Fox Chase Cancer Center never rests on its laurels. Every day, Fox Chase faculty, fellows, and residents discover innovative, life-enhancing cancer therapies and deliver care in the most compassionate way.
INSITE Trial Looking to Identify Which Patients Can Forgo Cystectomy
Alexander Kutikov, MD, FACS, and Matthew R. Zibelman, MD, are conducting a new trial called INSITE to attempt to answer that question.
Jay Simhan, MD, FACS, has been named Chair of the Department of Urology at Temple University Hospital and the Lewis Katz School of Medicine at Temple University.
When it comes to defeating cancer, Fox Chase Cancer Center never rests on its laurels. Every day, Fox Chase faculty, fellows, and residents discover innovative, life-enhancing therapies for deadly cancers and deliver care in the most compassionate ...
This year, Fox Chase faculty and Fellows presented research that revealed tangible benefits for genitourinary cancer patient outcomes and quality of life.
Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies
The Fox Chase genitourinary oncology team cover the latest advancements in surgical techniques, radiation therapies, and medical treatments for both localized and advanced bladder, kidney, and prostate cancers.